The GLYCOMARK (1,5-AG) ASSAY Advantages

THE GLYCOMARK (1,5-AG) ASSAY ADVANTAGES

  • Reveals recent deterioration in control not yet visible in HbA1c and glycated albumin
  • Shows therapy change improvement within 2 weeks
  • Can use fasting and non-fasting specimens
  • There is no ordering frequency limitation so the test can be ordered as needed
  • Reimbursed by Medicare, Medicaid, and most private payers

  • Faster than HbA1c at assessing changes in glycemic control to changes in treatment program or patient non-adherence.
  • Identify hyperglycemic excursions that may not be evident from standard glycemic markers.
  • Reflective of glucose levels above the renal threshold (~180 mg/dL).
  • Nearly 40% of diabetes patients in "good control" have significant glucose variability.

INTERPRETATION OF THE GLYCOMARK (1,5-AG) TEST RESULTS

  • Abnormal 1,5-AG levels are an indicator of hyperglycemic episodes within the last 1-2 weeks, which may have occurred in the fasting state, post-meal state, or both.
  • Changes in 1,5-AG levels reflect progression towards (increasing 1,5-AG) or away from (decreasing 1,5-AG) glycemic control.